Trends in upper gastrointestinal bleeding management  

作　　者：Yasir M Khayyat 

机构地区：[1]Department of Medicine,Faculty of Medicine,Umm AL-Qura University,Makkah 8156-24381,Saudi Arabia

出　　处：《World Journal of Clinical Cases》2024年第27期6007-6010,共4页世界临床病例杂志

摘　　要：Upper gastrointestinal bleeding(UGIB)can be attributed to either non-variceal or variceal causes.The latter is more aggressive with hemodynamic instability secondary to decompensated cirrhosis and portal hypertension.Non-variceal UGIB(NVUGIB)occurs due to impaired gastroprotective mechanisms attributed to several drugs such as anticoagulants and nonsteroidal anti-inflammatory drugs.Helicobacter pylori infection contributes to the development of peptic ulcer bleeding as well.NVUGIB presentation can be either hemodynamically stable or unstable.During the initial assessment a scoring system including patient-related factors(current cardiac,renal,and liver diseases and hemodynamic and labo-ratory parameters)is used to determine the patient’s prognosis.The Glasgow Blatchford score has been shown to be the most useful and precise.Those with high-risk NVUGIB require urgent assessment and upper endoscopy to achieve better short-term and long-term outcomes such as less hospitalization,blood transfusion,and surgery.

关 键 词：GASTRIC PEPTIC Non-steroidal anti-inflammatory drugs ANTICOAGULANTS MELENA 

分 类 号：R573.2[医药卫生—消化系统]